Ambit Biosciences Obtains $50,000,000 New Funding

  • Feed Type
  • Date
    11/6/2012
  • Company Name
    Ambit Biosciences
  • Mailing Address
    4215 Sorrento Valley Blvd. San Diego, CA 92121
  • Company Description
    Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.
  • Website
    http://www.ambitbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This financing, with OrbiMed Advisors leading a round in which all existing investors participated, is a strong vote of confidence in our direction and provides the resources to accelerate our progress in 2013.
  • M&A Terms
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    Aisling Capital
  • Venture Investor
    Roche Venture Fund
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Forward Ventures
  • Venture Investor
    Growthworks Capital
  • Venture Investor
    GIMV
  • Venture Investor
    Radius Ventures

By posting a comment, you agree to our terms and conditions.